Nexavar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Radioiodine therapy of metastatic differentiated thyroid cancer is a highly effective method of treatment which makes it possible…
Sorafenib (Nexavar®, BAY 43-9006) is a novel multikinase inhibitor that has been recently approved for the treatment of advanced…
Controversies surrounding government walk-in rights or patent eligibility that grabbed headlines in recent weeks presage broader…
OBJECTIVE
To study the therapeutic effects of Nexavar on liver cancer and its relation to the expressions of Ki-67 and CD34…
Sorafenib (NexavarⓇ) is an oral multikinase inhibitor that was recently approved for use in metastatic renal cancer. It is…
In 2006, specialty drugs were the largest category driving drug cost and utilization trends, contributing more to spending growth…
Since its FDA approval in December 2005, sorafenib (Nexavar) has been in use for the treatment of metastatic renal cell carcinoma…